Video Buzz v1
Highlighting streaming videos you should be watching
RelatedLinks
November 14th
September 10th
August 27th
August 21st
August 19th
- Medem: Medical Library: Eyelid Margin Disease, Including Blepharitis
- Granulated Eyelids or Blepharitis
June 27th
- Ophthalmology Management
- Favorable profile makes azithromycin a rationale choice for anterior and posterior blepharitis - Evaluations by independent investigators showed drug was safe, well tolerated - Ophthalmology Times Asia
- 08chicago-2-so lomon-Advanced Treatment.pdf (application/p df Object)
May 21st
- " Blepharitis Patients Rely on Motorcycle Glasses : Polarized Sun Glasses Blog
- Lid Scrub Methods and Lid Hygiene Products
- The Eyesite - Eye surface and Cornea Information Pages
- Blepharitis - Eye Care | Park Nicollet Health Services
May 4th
- Introduction: Blepharitis - CureResearch.c om
RelatedImages
Video Buzz > Blepharitis
Related Blepharitis News
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced ... - MSN MoneyCentral
ImClone Systems Incorporated IMCL today announced the commercial launch of ERBITUX ® (cetuximab) in Canada for use in the treatment of metastatic colorectal cancer (mCRC). Bristol-Myers Squibb collaborates with ImClone on ERBITUX in North America ...
Lux Biosciences to Present at Lazard Capital Markets 5th Annual ... - Phramalive.com
JERSEY CITY, N.J.--(BUSINESS WIRE)--Nov. 11, 2008 - Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Ulrich Grau, President and CEO, will present a company overview at ...
EKC-Cide Study Results Presented at National Ophthalmology Meeting - PR Inside
- NanoViricides, Inc. Amanda Schuon, 310-550-7200 info@nanoviricides.com NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that the Feinstein Institute of Medical Research scientists presented their study of the "Effect of Topical ...
New England Journal of Medicine Study Shows ERBITUX(R) Improves ... - PR Newswire
NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced today results from a multicenter, open-label, randomized Phase III trial, published in the New England ...
Study Published in New England Journal of Medicine Shows K-ras Gene ... - Earthtimes
NEW YORK - (Business Wire) ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced the publication of study results showing that metastatic colorectal cancer (mCRC) patients with wild-type or ...
Blepharitis Podcasts
Do you prefer to listen to your blepharitis gossip? Check out Podzy Podcast Directory > Blepharitis.
Blepharitis Products
Looking for blepharitis related products, then look no further. Try our new Blepharitis Shop.